Guillaume Cettou contributes to democratizing data-driven medicine by building data and analytics partnerships with BioPharma globally, as the Global Head of Data Partnerships at SOPHiA GENETICS. With a strategic vision of precision medicine, he is helping reshape the future of cancer care by forging collaborations that leverage AI to unlock actionable insights from multimodal data to support clinical decision-making and create a global network of collective intelligence. Guillaume has a passion for economics, innovation, and leadership, which led him to join SOPHiA GENETICS in 2021, as business development manager, after starting his career at McKinsey & Co. as a management consultant, moving to biotech at Amgen in sales & marketing.
Today, medicine stands at the edge of a data-driven revolution. With healthcare generating more data than ever before, the challenge lies in making sense of this complexity to drive real-world impact. AI-powered technologies are leading the charge to meet this challenge, accelerating innovation, improving patient outcomes, and advancing more equitable care on a global scale.
In this session, we will explore how AI and collective intelligence are translating vast amounts of data into actionable insights, enabling clinicians to make more informed decisions and improving outcomes across borders.
· Learn how AI is redefining real-world healthcare by transforming data complexity into valuable insights that unlock groundbreaking medical advancements and reshape care delivery.
· Explore how a connected network of healthcare institutions is powering global collaboration by creating a feedback loop of knowledge, leading to patient benefits worldwide.
· Discover how a decentralized, cloud-based AI technology is bridging the gap in cancer care, paving the way for a connected future, where the patients of today are helping the patients of tomorrow.